Biolex, Inc. Pulls Planned IPO Due to Market Conditions Published: Feb 04, 2008 WASHINGTON, Feb 1 (Reuters) - Clinical-stage biopharmaceutical company Biolex Inc on Friday canceled a planned initial public offering, citing market conditions. Related links Reuters This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news